Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

[1]  E. O’Reilly,et al.  Pancreatic Cancer: A Review. , 2021, JAMA.

[2]  Bechien U. Wu.  Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention , 2021, Current opinion in gastroenterology.

[3]  A. Klein.  Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors , 2021, Nature Reviews Gastroenterology & Hepatology.

[4]  Goutham Rao,et al.  Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer , 2021, Annals of Surgical Oncology.

[5]  L. Engstrand,et al.  Pancreatic cancer cachexia: three dimensions of a complex syndrome , 2021, British Journal of Cancer.

[6]  A. Kimmelman,et al.  Harnessing metabolic dependencies in pancreatic cancers , 2021, Nature Reviews Gastroenterology & Hepatology.

[7]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[8]  Fabian M. Troschel,et al.  Population-Scale CT-based Body Composition Analysis of a Large Outpatient Population Using Deep Learning to Derive Age-, Sex-, and Race-specific Reference Curves. , 2020, Radiology.

[9]  C. Sander,et al.  Diabetes, Weight Change, and Pancreatic Cancer Risk. , 2020, JAMA oncology.

[10]  Kenneth A. Philbrick,et al.  Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. , 2019, Gastroenterology.

[11]  Nguyen Phuoc Long,et al.  A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer , 2018, Metabolomics.

[12]  H. Woodrow,et al.  : A Review of the , 2018 .

[13]  Albert C. Koong,et al.  Altered exocrine function can drive adipose wasting in early pancreatic cancer , 2018, Nature.

[14]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[15]  M. Korc,et al.  Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer , 2017, Diabetes.

[16]  J. Winter,et al.  Pancreatic Cancer: A Review. , 2016, Gastroenterology clinics of North America.

[17]  M. Heo,et al.  Why are there race/ethnic differences in adult body mass index–adiposity relationships? A quantitative critical review , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[18]  Peter Kraft,et al.  Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development , 2014, Nature Medicine.

[19]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[20]  M. Karsdal,et al.  Serological muscle loss biomarkers: an overview of current concepts and future possibilities , 2012, Journal of cachexia, sarcopenia and muscle.

[21]  A. Greenberg,et al.  Sex differences in human adipose tissues – the biology of pear shape , 2012, Biology of Sex Differences.

[22]  Ananda Basu,et al.  Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes Mellitus , 2011, Pancreas.

[23]  Mariza de Andrade,et al.  Temporal Association of Changes in Fasting Blood Glucose and Body Mass Index With Diagnosis of Pancreatic Cancer , 2009, The American Journal of Gastroenterology.

[24]  L. Traverso,et al.  Exocrine function following the whipple operation as assessed by stool elastase , 2006, Journal of Gastrointestinal Surgery.

[25]  D. Finkelstein,et al.  Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Mariza de Andrade,et al.  Probability of pancreatic cancer following diabetes: a population-based study. , 2005, Gastroenterology.

[27]  Stanley Heshka,et al.  Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. , 2004, Journal of applied physiology.

[28]  Stanley Heshka,et al.  Visceral adipose tissue: relations between single-slice areas and total volume. , 2004, The American journal of clinical nutrition.

[29]  Claude Pichard,et al.  Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index. , 2003, Nutrition.

[30]  L. C. Rose,et al.  Assessment of abnormal growth curves. , 1998, American family physician.

[31]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[32]  J. Myles,et al.  Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma. , 1992, Annals of surgery.

[33]  M. de Andrade,et al.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. , 2008, Gastroenterology.

[34]  R. Ross,et al.  Human body composition: advances in models and methods. , 1997, Annual review of nutrition.